We are live on ! Find out more
RKDA icon

Arcadia Biosciences
RKDA

18 hedge funds and large institutions have $2.44M invested in Arcadia Biosciences in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 2

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

24% more capital invested

Capital invested by funds: $1.97M → $2.44M (+$466K)

20% more funds holding

Funds holding: 15 → 18 (+3)

0.05% more ownership

Funds ownership: 0.15% → 0.2% (+0.05%)

Holders
18
Holders Change
+3
Holders Change %
+20%
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
6
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$729K
2
GCP
GSA Capital Partners
United Kingdom
+$341K
3
AAP
Ardsley Advisory Partners
Connecticut
+$84.5K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$58.9K
5
LPL Financial
LPL Financial
California
+$24.6K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$113K
2
Morgan Stanley
Morgan Stanley
New York
-$37.5K
3
BlackRock
BlackRock
New York
-$3.38K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$770K +$729K +5,395 +362%
Vanguard Group
2
Vanguard Group
Pennsylvania
$718K – – –
GCP
3
GSA Capital Partners
United Kingdom
$283K +$341K +2,526 New
Geode Capital Management
4
Geode Capital Management
Massachusetts
$137K – – –
AAP
5
Ardsley Advisory Partners
Connecticut
$70K +$84.5K +626 New
LPL Financial
6
LPL Financial
California
$64K +$24.6K +182 +47%
BlackRock
7
BlackRock
New York
$61K -$3.38K -25 -4%
Northern Trust
8
Northern Trust
Illinois
$60K +$10.1K +75 +16%
HighTower Advisors
9
HighTower Advisors
Illinois
$57K +$24K +178 +54%
Wells Fargo
10
Wells Fargo
California
$54K +$8.78K +65 +16%
Susquehanna International Group
11
Susquehanna International Group
Pennsylvania
$49K +$58.9K +436 New
Dimensional Fund Advisors
12
Dimensional Fund Advisors
Texas
$42K – – –
CA
13
Calton & Associates
Florida
$36K – – –
UBS Group
14
UBS Group
Switzerland
$11K +$9.59K +71 +309%
TRCT
15
Tower Research Capital (TRC)
New York
$10K +$12.4K +92 New
BWM
16
BNC Wealth Management
Oregon
$7K +$8.78K +65 New
Morgan Stanley
17
Morgan Stanley
New York
$3K -$37.5K -278 -91%
CA
18
Clearstead Advisors
Ohio
$3K – – –
VF
19
Virtu Financial
New York
– -$113K -749 Closed

RKDA Hedge Fund Activity: Q3 2020 in Review

18 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Arcadia Biosciences (RKDA) for Q3 2020, worth a combined $2.44M — up 24% from $1.97M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new RKDA positions and 2 closed out — a net gain of 3 holders — while 6 added to existing stakes and 2 trimmed.

The largest buyer was Sabby Management, adding an estimated $729K. The largest seller was Virtu Financial, exiting entirely with an estimated $113K sold.

  • 18 institutional investors held Arcadia Biosciences (RKDA) as of Q3 2020, up from 15 in Q2 2020.
  • Funds reported $2.44M of Arcadia Biosciences stock for Q3 2020, up 24% quarter-over-quarter.
  • 5 funds opened new Arcadia Biosciences positions in Q3 2020 and 2 closed out, a net change of +3 holders.
  • The largest Arcadia Biosciences buyer in Q3 2020 was Sabby Management, an estimated $729K added.
  • The largest Arcadia Biosciences seller in Q3 2020 was Virtu Financial, an estimated $113K sold.

Based on aggregated 13F filings for Q3 2020.